Purchase Order 75N91018P00768

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $8,544.00 on November 8, 2017, with ultimate completion November 7, 2018. Performance takes place in Bethesda, Maryland. The order covers life science research instrumentation and related supplies on a firm fixed-price basis. No set-aside applies.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $5,310.80 on August 28, 2017, with ultimate completion on July 16, 2018. The order is for life science research supplies and equipment sourced from Bio-Rad's Life Science Group Division. Place of performance is Bethesda, Maryland. No set-aside was used; the award carries firm fixed-price pricing on a full-and-open competitive basis.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $4,729.00 on June 11, 2018, with an ultimate completion date of August 10, 2019. No set-aside was used. Performance takes place at Bethesda, Maryland. The order is for life science research equipment or supplies from Bio-Rad's Life Science Group Division on a firm fixed-price basis.</p>

The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc., Life Science Group Division, on September 5, 2018, with a ceiling value of $11,320.28 and an ultimate completion date of September 4, 2019. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is firm fixed price, covering life science research and clinical diagnostic equipment, reagents, or maintenance services characteristic of Bio-Rad's federal portfolio in analytical laboratory...

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $219,240.50 on August 27, 2014, with an ultimate completion date of August 26, 2015. No set-aside was used. Performance takes place in Bethesda, Maryland. The order is priced on a firm fixed-price basis. The source does not specify the particular equipment, supplies, or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $5,282.75 on September 7, 2017, with completion by October 8, 2017. No set-aside applied. Place of performance is Bethesda, Maryland. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. on August 16, 2016, with a ceiling value of $3,657.02 and an ultimate completion date of September 16, 2017. The order is firm fixed price with no set-aside. Work is performed in Bethesda, Maryland. Bio-Rad supplied laboratory equipment and instrumentation to support the Institute's research operations.</p>

<p>The National Cancer Institute issued a purchase order to Bio-Rad Laboratories, Inc. for $7,500.00 on August 9, 2017, with ultimate completion by August 13, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The order is for life science research equipment or related supplies and services from Bio-Rad's Life Science Group Division.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $1,284.75 on November 13, 2015, with completion on November 14, 2016. No set-aside was used. Performance is located in Bethesda, Maryland. The order is firm fixed price. The specific equipment or reagent items procured are not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Bio-Rad Laboratories, Inc. (Life Science Group Division) for $4,151.40 on April 18, 2018, with ultimate completion on April 25, 2019. No set-aside was used. Performance occurred in Bethesda, Maryland. The order was issued as a firm fixed-price service contract renewal. Specific commodities or services procured are not detailed in the source.</p>